Molina Healthcare

Zenni® Optical Announces 'Zenni Business' Customers

Retrieved on: 
Tuesday, March 5, 2024

NOVATO, Calif., March 4, 2024 /PRNewswire/ -- Zenni Optical, the world's leading online eyewear retailer, today announced eye care solutions partnerships with four customers of Zenni Business, its recently-launched B2B platform.

Key Points: 
  • Zenni's B2B platform has its roots in an unmatched expertise developed during its more than two decades transforming the consumer eyewear industry.
  • Zenni Business intends to challenge an eye care industry plagued by high costs, stifled innovation and consumer access limitations.
  • With its vertically integrated business model that includes ownership of optical laboratories, manufacturing and logistics, frame design, technology and customer service, Zenni can control costs and help its business partners benefit from existing infrastructure and marketplace knowledge.
  • "We identified a strategic opportunity to revolutionize this industry, and the response to Zenni Business has been extremely positive.

A Partnership in Healing: Virtue Recovery Center Las Vegas Welcomes Molina Healthcare Insurance

Retrieved on: 
Monday, March 4, 2024

LAS VEGAS, March 4, 2024 /PRNewswire-PRWeb/ -- A Partnership in Healing: Virtue Recovery Center Las Vegas Welcomes Molina Healthcare Insurance

Key Points: 
  • Individuals covered under Molina Healthcare insurance now have the opportunity to receive holistic treatment at Virtue Recovery Center Las Vegas, which includes a range of services from detoxification to rehabilitation and beyond.
  • LAS VEGAS, March 4, 2024 /PRNewswire-PRWeb/ -- A Partnership in Healing: Virtue Recovery Center Las Vegas Welcomes Molina Healthcare Insurance
    Virtue Recovery Las Vegas partners with Molina Healthcare, representing a monumental step in the mission to make comprehensive addiction recovery services accessible to everyone in need.
  • Virtue Recovery Center in Las Vegas has announced a new collaboration with Molina Healthcare, marking a pivotal step in bridging the gap between the need for comprehensive addiction care and the financial barriers that often hinder access to such services.
  • Individuals covered under Molina Healthcare insurance now have the opportunity to receive holistic treatment at Virtue Recovery Center Las Vegas, which includes a range of services from detoxification to rehabilitation and beyond.

After a successful Series B fundraising round from Seoul Clinical Laboratories (Korea), Standard Foods and and AWS cloud services representative GrandTech C.G. Systems (Taiwan), H2U secured over 10 million USD in funds

Retrieved on: 
Sunday, February 25, 2024

TAIPEI, Taiwan, Feb. 24, 2024 /PRNewswire/ -- Taiwan's leading digital health brand, H2U, ushered in the lunar new year with exciting news. Entities such as Korea's largest medical laboratory, Seoul Clinical Laboratories (SCL), Taiwan's biggest food company, Standard Foods, the leading protein and antibody reagent innovator and manufacturer, Leadgene Biomedical, and AWS cloud services representative, GrandTech C.G. Systems, have enthusiastically joined H2U's current round of fundraising (Series B) before the lunar new year, raising over 10 million USD in funds. Prior to this round, H2U had already secured investments from reputable institutional investors, including Foxconn Technology, ADATA, TOPCO, UDN, WeLeader Bio, Flight International, Wondercise, and Sparklabs.

Key Points: 
  • H2U is expanding its reach to South Korea through a SaaS-based digital health check platform and a closed-loop post-check health management program.
  • TAIPEI, Taiwan, Feb. 24, 2024 /PRNewswire/ -- Taiwan's leading digital health brand, H2U, ushered in the lunar new year with exciting news.
  • Entities such as Korea's largest medical laboratory, Seoul Clinical Laboratories (SCL), Taiwan's biggest food company, Standard Foods, the leading protein and antibody reagent innovator and manufacturer, Leadgene Biomedical, and AWS cloud services representative, GrandTech C.G.
  • Systems, have enthusiastically joined H2U's current round of fundraising (Series B) before the lunar new year, raising over 10 million USD in funds.

After a successful Series B fundraising round from Seoul Clinical Laboratories (Korea), Standard Foods and and AWS cloud services representative GrandTech C.G. Systems (Taiwan), H2U secured over 10 million USD in funds

Retrieved on: 
Sunday, February 25, 2024

TAIPEI, Taiwan, Feb. 25, 2024 /PRNewswire/ -- Taiwan's leading digital health brand, H2U, ushered in the lunar new year with exciting news. Entities such as Korea's largest medical laboratory, Seoul Clinical Laboratories (SCL), Taiwan's biggest food company, Standard Foods, the leading protein and antibody reagent innovator and manufacturer, Leadgene Biomedical, and AWS cloud services representative, GrandTech C.G. Systems, have enthusiastically joined H2U's current round of fundraising (Series B) before the lunar new year, raising over 10 million USD in funds. Prior to this round, H2U had already secured investments from reputable institutional investors, including Foxconn Technology, ADATA, TOPCO, UDN, WeLeader Bio, Flight International, Wondercise, and Sparklabs.

Key Points: 
  • H2U is expanding its reach to South Korea through a SaaS-based digital health check platform and a closed-loop post-check health management program.
  • TAIPEI, Taiwan, Feb. 25, 2024 /PRNewswire/ -- Taiwan's leading digital health brand, H2U, ushered in the lunar new year with exciting news.
  • Entities such as Korea's largest medical laboratory, Seoul Clinical Laboratories (SCL), Taiwan's biggest food company, Standard Foods, the leading protein and antibody reagent innovator and manufacturer, Leadgene Biomedical, and AWS cloud services representative, GrandTech C.G.
  • Systems, have enthusiastically joined H2U's current round of fundraising (Series B) before the lunar new year, raising over 10 million USD in funds.

Westat Awarded Contract to Continue Supporting the PATH Study

Retrieved on: 
Wednesday, February 21, 2024

ROCKVILLE, Md., Feb. 21, 2024 /PRNewswire/ -- The National Institutes of Health's (NIH's) National Institute on Drug Abuse (NIDA) and the U.S. Food and Drug Administration's (FDA's) Center for Tobacco Products (CTP) have announced the award of a third contract to Westat to continue to support the Population Assessment of Tobacco and Health (PATH) Study. Westat has supported the study since its inception in 2011.

Key Points: 
  • Westat is committed to continuing the trusted partnership with NIH/NIDA and FDA/CTP on the Population Assessment of Tobacco and Health (PATH) Study to understand tobacco use patterns and impacts on public health.
  • Westat has supported the study since its inception in 2011.
  • The PATH Study is a uniquely large, long-term study of tobacco use and health in the United States.
  • "Our work will build on the knowledge we have gained during the past 12 years of supporting the PATH Study and a foundation of over 35 years of tobacco research," notes Charles Carusi, PhD , a Westat Vice President and the project director for the PATH Study.

OCCUPATIONAL HEALTH PHYSICIAN URGES CHICAGOANS TO WEAR MASKS/GET VACCINATED

Retrieved on: 
Friday, February 16, 2024

"The latest variant, JN.1, is highly contagious and is driving transmissions, but the newest booster is helping to prevent the spread," Dr. Fletcher says.  "Yet only 20 percent of adults have received the latest vaccine.  It's important to get vaccinated -- especially high-risk patients who have underlying health conditions or are immunosuppressed."

Key Points: 
  • , public health specialist and CEO of SafeWorks Illinois , advises individuals and companies to take measures to prevent the spread of viruses and bacterial-related illnesses over the winter months.
    "
  • The latest variant, JN.1, is highly contagious and is driving transmissions, but the newest booster is helping to prevent the spread," Dr. Fletcher says.  "
  • It's important to get vaccinated -- especially high-risk patients who have underlying health conditions or are immunosuppressed."
  • SafeWorks Illinois offers worker's compensation, occupational health services and corporate programs to create safe, drug-free businesses and industries.

Multi Board-Certified Physician Sam Setareh Opens MDVIP-Affiliated Primary Care Practice in Los Angeles

Retrieved on: 
Wednesday, February 14, 2024

LOS ANGELES and BOCA RATON, Fla., Feb. 14, 2024 /PRNewswire/ -- MDVIP, the market leader in personalized healthcare with a network of over 1,100 physicians nationwide, today announced the opening of a new MDVIP-affiliated internal medicine practice in Los Angeles. Sam Setareh, M.D., M.S., F.A.C.C., is currently accepting patients who want a more direct relationship with their primary care physician. Dr. Setareh brings an impressive and diversified background to MDVIP, including four board certifications in Internal Medicine, Cardiovascular Disease, Nuclear Cardiology and Echocardiology, and he is an attending physician at Cedars-Sinai Medical Center in Los Angeles.  Dr. Setareh serves as a member of multiple committees on the American College of Cardiology and the American Heart Association and as a founding member of the editorial board of The Journal of Scientific Innovation in Medicine.

Key Points: 
  • , is currently accepting patients who want a more direct relationship with their primary care physician.
  • Dr. Setareh brings an impressive and diversified background to MDVIP, including four board certifications in Internal Medicine, Cardiovascular Disease, Nuclear Cardiology and Echocardiology, and he is an attending physician at Cedars-Sinai Medical Center in Los Angeles.
  • "As an MDVIP-affiliated primary care physician, my mission is to help empower patients to take better control of their health through preventive medicine and highly individualized care," said Dr. Setareh, who has subspecialties in preventive cardiology, sports cardiology and advanced cardiovascular imaging.
  • He has treated and taken care of patients from all walks of life, including the most vulnerable to heads-of-state, dignitaries, athletes, celebrities and physician colleagues.

Senior Whole Health by Molina Healthcare Invests $500,000 in Place-Based Supports to Reduce Health Disparities for Seniors in Massachusetts Affordable Housing Sites

Retrieved on: 
Wednesday, February 14, 2024

Senior Whole Health by Molina Healthcare (“Senior Whole Health”) in collaboration with The MolinaCares Accord (“MolinaCares”) is announcing a $500,000 investment in organizations providing place-based supports (PBS) for residents of senior affordable housing sites.

Key Points: 
  • Senior Whole Health by Molina Healthcare (“Senior Whole Health”) in collaboration with The MolinaCares Accord (“MolinaCares”) is announcing a $500,000 investment in organizations providing place-based supports (PBS) for residents of senior affordable housing sites.
  • The resources will enhance care and wellness for facility residents across greater Boston.
  • It leverages on-site resident service coordinators (RSCs) who help seniors access health care providers, health plans, and community organizations.
  • “Improving health outcomes for older adults in Massachusetts goes beyond providing traditional medical services,” said Bill Graham, plan president for Senior Whole Health by Molina Healthcare.

The Future of Single Chamber ICDs: BIOTRONIK Takes Unprecedented Market Stance with Proprietary DX Technology

Retrieved on: 
Monday, February 12, 2024

"We are very proud that our DX technology provides the only lead available on the market offering both ventricular pacing/defibrillation and atrial monitoring," said Ryan Walters, BIOTRONIK US President.

Key Points: 
  • "We are very proud that our DX technology provides the only lead available on the market offering both ventricular pacing/defibrillation and atrial monitoring," said Ryan Walters, BIOTRONIK US President.
  • "Due to DX´s ability to provide additional patient and clinical benefits, it became clear to us that we should be using DX technology with every BIOTRONIK single-chamber ICD."
  • Subclinical atrial fibrillation detection with a floating atrial sensing dipole in single lead implantable cardioverter-defibrillator systems: Results of the SENSE trial.
  • REACT DX registry: Real world REACTion to atrial high rate episodes detected in implantable cardioverter-defibrillator recipients with a DX lead.

Molina Healthcare of Illinois Expands Provider Network to Include Rush University System for Health

Retrieved on: 
Monday, February 12, 2024

Molina Healthcare of Illinois (“Molina”) announced Rush University System for Health (“Rush”) is now offered as a provider for its Medicaid, Marketplace, and MMP members in the Chicagoland area.

Key Points: 
  • Molina Healthcare of Illinois (“Molina”) announced Rush University System for Health (“Rush”) is now offered as a provider for its Medicaid, Marketplace, and MMP members in the Chicagoland area.
  • “Molina is pleased to offer members greater access to top providers like Rush,” said Matt Wolf, plan president for Molina Healthcare of Illinois.
  • “Molina will be working closely with Rush as our members begin visiting its hospitals and physicians to access the latest technology, resources, and health care.”
    Molina members have access to all four Rush hospitals including Rush University Medical Center, Rush Copley Medical Center, Rush Oak Park Hospital, and Riverside Medical Center.
  • “This new partnership will create greater access to the very best health care for more patients across the Chicago area and Northwest Indiana,” said Lisa Wagamon, president of Rush Health.